Delivery Order SPE2DB20D2014-SPE2DB25FB14M

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,253.28, is for the delivery of 4567258486 - Tranexamic 1,000 mg/100 ml-Nacl 100 ml medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,210.52 firm fixed-price delivery order is for the supply of 4,566,577,212 units of Tranexamic 1,000 mg/100 ml-Nacl 100 ml, a medication used to treat and prevent excessive bleeding. The contract has a completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,032.42, is for the delivery of 4561087760 - Tranexamic 1000mg 10s, a pharmaceutical product. This contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,255.23, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of 4562149915 TRANEXAMIC 1000MG 10S, a pharmaceutical product, to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,866.85, is for the delivery of tranexamic acid 1,000 mg/100 ml sodium chloride 100 ml solution. This is a firm-fixed-price delivery order contract with a completion date of November 18, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,675.54 contract is for the supply of 4,566,908,730 units of Tranexamic 1,000 mg/100ml-Nacl 100ml, a medical product used for healthcare purposes. The award is not associated with a set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Tranexamic Acid 650 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,298.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024. The contract has an ultimate completion date of September 9, 2024 and is a Firm Fixed Price Delivery Order. No set-aside was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,098.18 firm fixed-price delivery order is for the supply of 4,562,494,030 units of tranexamic acid 1,000 mg/100 mL in sodium chloride 100 mL. The contract has an ultimate completion date of October 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $166,566.12, is a delivery order with a firm fixed price and an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB14M
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,088.80, is a delivery order for 4567341035 TRANEXAMIC 1,000 MG/100ML-NACL 100ML. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is not designated with a set-aside requirement, indicating open competition.

Generated 5/23/25, 9:59 AM